- Report
- July 2023
- 128 Pages
North America
From €1310EUR$1,500USD£1,138GBP
- Report
- July 2023
- 141 Pages
Middle East, Africa
From €1310EUR$1,500USD£1,138GBP
- Report
- October 2023
- 176 Pages
Global
From €3886EUR$4,450USD£3,376GBP
- Report
- February 2023
- 151 Pages
North America
From €3013EUR$3,450USD£2,617GBP
- Report
- December 2022
- 185 Pages
Africa, Middle East, Turkey Africa, Middle East, Turkey
From €3013EUR$3,450USD£2,617GBP
- Report
- February 2024
- 145 Pages
Global
From €2969EUR$3,400USD£2,579GBP
€3712EUR$4,250USD£3,224GBP
- Report
- June 2025
- 250 Pages
Japan
From €2436EUR$2,789USD£2,116GBP
- Report
- April 2023
- 147 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- April 2023
- 147 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- April 2023
- 147 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Drug Pipelines
- June 2023
- 122 Pages
Global
From €13095EUR$14,995USD£11,376GBP
- Report
- May 2024
- 160 Pages
Global
From €4339EUR$4,969USD£3,770GBP
- Report
- July 2024
- 154 Pages
Global
From €3155EUR$3,613USD£2,741GBP
€3712EUR$4,250USD£3,224GBP
- Report
- November 2023
- 224 Pages
Global
€4362EUR$4,995USD£3,790GBP
- Report
- January 2023
- 276 Pages
Global
From €3144EUR$3,600USD£2,731GBP
- Drug Pipelines
- June 2023
- 150 Pages
Global
From €13095EUR$14,995USD£11,376GBP
- Report
- March 2025
- 230 Pages
China
From €3493EUR$4,000USD£3,035GBP
- Report
- March 2025
- 86 Pages
China
From €1572EUR$1,800USD£1,366GBP
- Report
- February 2025
Germany
From €1266EUR$1,450USD£1,100GBP
- Report
- February 2025
United Kingdom
From €1266EUR$1,450USD£1,100GBP

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones.
The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare.
Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more